New Analyst Forecast: $SOC Given $37.0 Price Target

Roth Capital set a price target of $37.0 for SOC, while insider trading activity over the last six months shows GLOBAL ICAV PILGRIM sold 143,806 shares. Q1 2025 institutional investor activity reveals mixed sentiment, with ADAGE CAPITAL PARTNERS GP, L.L.C. decreasing its position by 2,868,621 shares and ENCOMPASS CAPITAL ADVISORS LLC increasing its position by 1,294,954 shares.

Analysis

Roth Capital has established a price target of $37.0 for $SOC, providing a new valuation benchmark. Insider trading activity over the past six months reveals a single transaction: a sale by GLOBAL ICAV PILGRIM of 143,806 shares, valued at approximately $3.65 million. Institutional activity in the most recent quarter (Q1 2025) indicates a divergence in sentiment; while 116 institutions added $SOC shares and 78 reduced their positions, there were significant reallocations. Notably, ADAGE CAPITAL PARTNERS GP, L.L.C. decreased its holdings by 2,868,621 shares (-89.7%), and ALYESKA INVESTMENT GROUP, L.P. liquidated its entire position of 607,286 shares. Conversely, ENCOMPASS CAPITAL ADVISORS LLC increased its stake by 1,294,954 shares (+92.5%), and MORGAN STANLEY augmented its holdings by 521,357 shares (+209.3%). This mixed institutional flow, alongside the insider sale, suggests a period of re-evaluation for $SOC among large investors.

Key Decisions for Investors

• Investors should consider the new $37.0 price target from Roth Capital in their valuation models, while noting the recent insider sale as a potential point of caution.
• The divergent institutional activity, with significant sales by firms like Adage Capital and Alyeska contrasted by substantial purchases from Encompass Capital and Morgan Stanley, warrants a closer examination of individual fund theses and suggests potential for increased stock volatility.
• Given the mixed signals from institutional investors and the isolated insider selling, maintaining a neutral stance or conducting further due diligence on underlying catalysts for $SOC may be prudent before adjusting positions significantly.